Formulary Drug Review: Etelcalcetide
1Washington State University, Spokane, WA, USA.
Hospital Pharmacy
|December 26, 2017
Summary
The Formulary Monograph Service provides monthly drug monographs and utilization evaluations for Pharmacy & Therapeutics Committees. Subscribers receive detailed drug information and customizable resources for clinical decision-making.
Area of Science:
- Pharmacology
- Drug Information
- Clinical Pharmacy
Background:
- Pharmacy & Therapeutics Committees require up-to-date drug information for formulary decisions.
- New drug approvals and late-phase trials necessitate comprehensive evaluations.
- Effective medication use evaluations (MUE) are crucial for optimizing patient care and safety.
Purpose of the Study:
- To provide timely and detailed monographs on newly released or late-stage trial drugs.
- To offer concise summary monographs for pharmacy and nursing in-services.
- To deliver comprehensive drug utilization evaluations (DUE/MUE) for targeted agents.
Main Methods:
- Publication of 5-6 detailed monographs monthly.
- Inclusion of 1-page summary monographs for quick reference.
- Provision of a comprehensive DUE/MUE for a selected drug each month.
- Online accessibility of all monographs for subscribers.
Main Results:
- November 2017 topics included Ertugliflozin, Glecaprevir/pibrentasvir, Neratinib, Sofosbuvir, velpatasvir, voxilaprevir, and SQ C1 esterase inhibitor.
- A specific MUE focused on Glecaprevir and Pibrentasvir was provided.
- Monographs are customizable to facility-specific needs.
Conclusions:
- The Formulary Monograph Service offers a valuable, subscription-based resource for healthcare facilities.
- It supports informed formulary management and medication use through detailed drug information and evaluations.
- The service aids in clinical decision-making and educational initiatives for pharmacy and nursing staff.
Related Concept Videos
01:10Review and Preview
8.4K
In statistics, several tools are used to interpret the data. Measures of central tendency represent the characteristics of the data, such as mean, median, and mode. Additionally, measures of variance like standard deviation and range are used to find the spread of data from the mean. Relative standing measures the distance between data locations. Commonly used measures of relative standings are percentile, z score, and quartiles.
Percentiles are a type of fractile that partition data into...
Percentiles are a type of fractile that partition data into...
8.4K
01:13Review and Preview
11.6K
Data are individual items of information obtained from a population or sample. Data may be classified as qualitative (categorical), quantitative continuous, or quantitative discrete. Because it is not practical to measure the entire population in a study, researchers use samples to represent the population. A random sample is a representative group from the population chosen by using a method that gives each individual in the population an equal chance of being included in the sample. Random...
11.6K
01:30Drug toxicity: Drug–Drug Interaction
22
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
22
01:25Pharmacokinetics: Drug–Drug Interactions
477
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
477
01:09Bioequivalence of Drugs: Drugs with Multiple Indications
167
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
167
01:26FDA Approved Drugs: Changes to Approved Drugs
279
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
279